最新公告

最新公告 (548)

由於缺乏潛在的生物標誌物和治療靶標,導致口腔鱗狀細胞癌(OSCC)仍然是全世界癌症死亡的主要原因之一。因此,我們的研究重點放在找出具潛力的OSCC生物標誌物和治療靶標。我們已經從癌症基因組圖譜數據庫中分析口腔癌患者組織中的基因表現情形或進行siRNA庫篩選,藉由定量聚合酶鏈反應和免疫組織化學來比較OSCC患者正常及腫瘤組織中的基因表現來確認潛在的致癌基因和抑癌基因。我們還透過OSCC癌細胞和異種移植小鼠模型驗證了這些潛在生物標記物的作用和分子機制。到目前為止,我們已經發表幾篇具潛力的OSCC生物標誌物和治療靶標相關論文,如圖1所示。在這裡,我們介紹其中一個具潛力的生物標誌物和治療靶標-自噬相關蛋白酶4BATG4B),如圖2所示。

自噬相關蛋白酶4BATG4B)是自噬作用中不可少的蛋白酶,Ser383/392處磷酸化的ATG4B可增加其蛋白水解活性。 ATG4B的表現和活化對於癌細胞的增殖和侵襲相當重要。然而,ATG4BSer383/392處磷酸化的ATG4BOSCC患者臨床之關聯性仍然未知,尤其在頰黏膜SCCBMSCC)和舌頭SCCTSCC)患者中。使用498OSCC患者檢體做成組織微陣列,包括179BMSCC249TSCC患者,我們發現BMSCCTSCC患者腫瘤組織中的ATG4BSer383/392處磷酸化的ATG4B之蛋白表現量比鄰近組織正常中的要高。在OSCC患者中,特別是在晚期腫瘤患者中,高蛋白表現量的ATG4B與較差的疾病特異性生存率(DSS)有顯著相關。另外,Ser383/392處磷酸化的ATG4B1蛋白表現量與TSCC患者的不良無病生存率(DFS)也相關。此外,在BMSCCTSCC患者中,ATG4B蛋白表達量與Ser383/392處磷酸化ATG4B蛋白表現量呈現正相關。然而,僅在TSCC患者中,同時高蛋白表現量的ATG4BSer383/392處磷酸化的ATG4B與患者較差的DFS相關,而在BMSCCTSCC患者中,它們卻與患者DSS無顯著相關。此外,用反義寡核苷酸(ASO)或干擾RNAsiRNA)沉默ATG4B可以減少TW2.6SAS口腔癌細胞的細胞增殖。另外,剔除口腔癌細胞的ATG4B可以減少細胞遷移和侵襲。綜上所述,這些發現顯示,ATG4B可能作為未來OSCC患者的潛在生物標誌物和治療靶標。

生科 02 劉佩芬 CH口腔鱗狀細胞癌治療的新契機01

 

生科 02 劉佩芬 CH口腔鱗狀細胞癌治療的新契機02

本校主要研究者之簡介:

劉佩芬助理教授(生物醫學暨環境生物學系)

研究聯繫Email:

pfliu@kmu.edu.tw

期刊出處:

Cancers 2019, 11(12), 1854

研究全文下載:

https://www.mdpi.com/2072-6694/11/12/1854

Oral squamous cell carcinoma (OSCC) remains one of the major leading causes of cancer death worldwide due to the lack of potential biomarkers and therapeutic targets. Thus, our research is focusing on identifying potential biomarkers and therapeutic targets for OSCC. We have analyzed the gene expression in the tissues of oral cancer patients from the Cancer Genome Atlas database or performed siRNA library screening to identify potential oncogenes and tumor suppressive genes by comparing gene expression between normal and tumor tissue of OSCC patients with quantitative polymerase chain reaction and immunohistochemistry. We also verified roles and molecular mechanisms of these potential biomarkers by using OSCC cancer cells and xenografted mice models. So far, we have published several related papers with potential OSCC biomarkers and therapeutic targets, as shown in Figure 1. Here, we introduced one of the potential biomarkers and therapeutic targets-autophagy-related protease 4B (ATG4B), as shown in Figure 2.

 Autophagy related protease4B (ATG4B) is an essential protease for the autophagy machinery, and ATG4B phosphorylation at Ser383/392 increases its proteolytic activity. ATG4B expression and activation are crucial for cancer cell proliferation and invasion. However, the clinical relevance of ATG4B and phospho-Ser383/392-ATG4B for OSCC remains unknown, particularly in buccal mucosal SCC(BMSCC) and tongue SCC (TSCC). With a tissue microarray comprising specimens from 498 OSCC patients, including 179 BMSCC and 249 TSCC patients, we found that the protein levels of ATG4B and phospho-Ser383/392-ATG4B were elevated in the tumor tissues of BMSCC and TSCC compared with those in adjacent normal tissues. High protein levels of ATG4B were significantly associated with worse disease-specific survival (DSS) in OSCC patients, particularly in patients with tumors at advanced stages. In contrast, phospho-Ser383/392-ATG4B expression was correlated with poor disease-free survival (DFS) in TSCC patients. Moreover, ATG4B protein expression was positively correlated with phospho-Ser383/392-ATG4B expression in both BMSCC and TSCC. However, high coexpression levels of ATG4B and phospho-Ser383/392-ATG4B were associated with poor DFS only in TSCC patients, whereas they had no significant association with DSS in BMSCC and TSCC patients. In addition, silencing ATG4B with an antisense oligonucleotide (ASO) or small interfering RNA (siRNA) diminished cell proliferation of TW2.6 and SAS oral cancer cells. Further, knockdown of ATG4B reduced cell migration and invasion of oral cancer cells. Taken together, these findings suggest that ATG4B might be a potential biomarker and therapeutic target for OSCC patients in the future.

02 劉佩芬 EN口腔鱗狀細胞癌治療的新契機01

 

02 劉佩芬 EN口腔鱗狀細胞癌治療的新契機02

Main researcher Intro.

Assistant Professor Dr. Pei-Feng Liu

(Department of Biomedical Science and Environment Biology)

Author Email:

pfliu@kmu.edu.tw

Paper cited from:

Cancers 2019, 11(12), 1854

Research Paper available online on website:

https://www.mdpi.com/2072-6694/11/12/1854

遊戲教學:提升醫學生的性別素養與促進同志友善醫療

    醫學教育者如何善用教學方法,在教導學生專業學習之際,亦培育學生的性別素養?致力於性別與醫學教育研究的高雄醫學大學教授楊幸真,在〈教育為先:促進同志友善醫療的素養導向課程與遊戲教學〉論文中,分享如何在素養導向醫學教育觀點下,運用遊戲教學,創造一個具吸引力的教學活動,促進學生積極參與學習及提升學生的性別素養。

設計遊戲,教性別也教精神醫學

遊戲學習,是一種參與式的教育取徑,能讓學生一起腦力激盪,解決問題。該研究以精神醫學臨床教育醫學生為研究對象,設計「同志醫療與身心健康」課程及九宮格遊戲。九宮格遊戲除了做為暖身活動,引發學生學習動機外,亦做為學習評量工具,具有前測與形成性評量的功用。九宮格遊戲問題的設計,依循素養導向醫學教育的理念,從知識、態度與技能面向出題,了解學生對於同志醫療及精神健康議題方面的認識。

因為是遊戲,即使不會,也是令人愉快的挫敗感

素養,必須透過學習歷程才可能形成,無法直接灌輸。該研究從學生的回應發現,遊戲教學確實能協助教師整合性別與醫療健康照護知識於遊戲過程之中。更重要的是,對於同志醫療與健康議題而言,因為是遊戲,也較能去除學生給予政治正確的回答,能讓學生對於LGBT的認識,包括正確、錯誤、甚至是偏見,都能在遊戲過程中表露與對話,並藉由互動對話產生有意義的學習。

研究者與授課教師在設計九宮格問題時,原以為有些基本知識是學生一定知道且能夠回答的問題。但是,大多數醫學生不知道同性戀去病化是那一年,許多人不清楚何謂跨性別,以及少數人不知道LGBT代表的內涵。好的遊戲學習,具備挑戰性及令人愉悅挫敗感的特性。因為是遊戲,學生即使答不出來,也不會有挫折感。這種在遊戲之中經歷的挑戰與愉快挫敗感,反而更激發學生學習動力。如學生所言: “就更想知道其他題目是什麼”, “吸引我的注意力,不僅對於接續的性別與精神醫學概念講解更能專注聆聽,亦達到遊戲學習「探索」的功用,激發學生願意主動思考。

此外,做為教學活動與評量工具的九宮格遊戲,還具有支持學習與教學的功用。前者能發現學生的學習困難或迷思概念,以便適時提供學習鷹架,提升效能感。例如,該課程在遊戲進行之後進行概念教學,其中就包含對於同性戀去病化歷史及LGBT的介紹。課程亦安排同志敘說自身就醫經驗,藉由真實生命經驗敘說,以回應九宮格的問題,促進知識、態度與技能的統整學習。後者乃指遊戲的設計,易讓教師將評量融入教學,使評量成為教學方法與教學活動的一部分,而不是外加於教學的評價工具。

學習成效的提升,必得有策略地運用教學方法

該研究發現,遊戲讓學生有參與感,有效提升學生的學習動機及助益主動學習及知識探索。遊戲同時做為教學活動與評量工具,能落實素養導向教育重視學習過程中的評量與立即回饋。運用遊戲教學,確實能有效引領醫學生學習性別,促進將性別知識、態度與技能等多元能力統合納入精神醫學教育與學習之目標。

本校主要研究者之簡介:高雄醫學大學性別研究所教授楊幸真

研究聯繫Email: yhc@kmu.edu.tw

期刊出處:

Yang, H. C. (2019). Education first: Promoting LGBT+ friendly healthcare with a competency-based course and game-based teaching. International Journal of Environmental Research and Public Health, 17(1), 107; https://doi.org/10.3390/ijerph17010107

研究全文下載:https://reurl.cc/Y6dxEO

Game-Based Teaching: Enhancing Medical Students’ Gender Competency and Promoting LGBT Friendly Healthcare

 

How can medical educators make good use of teaching methods to cultivate medical students’ gender competency while teaching students psychiatry and healthcare education? Yang Hsing-Chen, a professor at Kaohsiung Medical University(KMU), who is devoted to the study of gender and medical education, responded to this question in her paper “Education First: Promoting LGBT Friendly Health Care with a Competency-Based Course and Game-Based Teaching.” Using the competency-based medical education (CBME) perspective and gender courses in psychiatric clinical education, this research paper explored whether the application of game-based teaching activities can promote gender learning and improve the gender competency of students.

 

Design games to teach gender and psychiatry

 

Game-based teaching and learning is a participatory educational approach in which students brainstorm together to solve problems. The research course, LGBT Health and Medical Care (LGBT HMC) was added to KMU psychiatric clinical education training for one academic year. According to the competency-based course and teaching design ideas, a 3 × 3-grid game was designed as the warm-up game for LGBT HMC. Apart from stimulating learning motivation, this game served as an evaluative tool, functioning as a pretest and formative evaluation. The aim of this game was to prompt learning motivation. It was designed to assess students’ prior LGBT knowledge–, which provided feedback informing the adjustment of the course and the improvement of learning conditions. Those questions of the 3 × 3 grid game were designed to elicit responses regarding students’ understanding of LGBT health care and mental health issues and could be answered from the perspectives of knowledge, attitudes, and skills.

 

“It’s a game, even if you don’t know the answer, it’s a pleasant frustration”

 

Using the 3 × 3 grid game as the teaching activity aimed to achieve two objectives: to trigger the learning motivation of students and encourage them to proceed to concept learning and to prevent lecturing on LGBT concepts from becoming an instance of the “banking education.” Because competency can only be formed through learning processes rather than through direct inculcation. Student responses revealed that game-based teaching can help teachers to convey and integrate gender and medical knowledge or concepts into a game; students can connect with the course content and experience knowledge transformation to achieve positive learning outcomes. With respect to LGBT medical and health care issues, within the context of a game, students were able to express and discuss their correct, incorrect, or even biased understanding regarding LGBT communities without being overly concerned with providing politically correct answers. These interactions and dialogues led to meaningful learning.

 

When Professor Yang and her researcher team and the teachers were designing the questions for the 3 × 3 grid game, the answers to some of the questions were considered basic knowledge that students must know and be capable of understanding. Surprisingly, none of these students, who had already commenced their internships in a hospital, could state the year in which homosexuality was removed from the classification of mental diseases. Numerous students did not know what “transgender” meant, and a few students were unfamiliar with the meaning of LGBT. As previously stated, successful game-based learning is adequately challenging and pleasantly frustrating. Experiencing challenges can also be positively stimulating in a game and provoke learning motivation among students; for example, one student stated that “You become curious about what the other questions are, and that draws my attention.” The students were more focused and invested in the following section of the course, which explained the concepts of LGBT health issues and psychiatry. The game achieved the exploratory function of game-based learning and provoked active thinking in students.

 

This study revealed that the 3 × 3 grid game, which served as the teaching activity and assessment tool, also supported learning and teaching. The game helps with learning by identifying difficulties and misconceptions experienced by students, and this enables the timely provision of instructional scaffolding to enhance efficacy. For example, the course was designed to conduct concept teaching after the game, and the concepts included the history of the removal of homosexuality from the classification of mental diseases and an introduction to LGBT communities. The teachers also invited LGBT individuals to the class to share their own medical experiences. These real-life experiences gave the answers to the questions in the game and helped the students with the integration of knowledge, attitudes, and skills. In addition, the game helps teaching because the design of the game facilitates the integration of assessment into teaching, which makes the assessment part of the teaching method and teaching activity rather than a supplementary evaluative tool. In fact, both aspects of the game can enhance assessment for teaching and exhibit the value of the instant feedback obtained in CBME and game-based learning.

 

Use teaching methods strategically to improve learning effectiveness

 

The findings of this study were as follows: (1) Games encouraged student participation and benefited gender knowledge transmission and transformation through competency learning. (2) Games embodied the idea of assessment as learning. The enjoyable feeling of pressure from playing games motivated students to learn. Using games as both a teaching activity and an assessment tool provides the assessment and instant feedback required in the CBME learning process. In short, game-based teaching successfully guides medical students to learn about gender and psychiatry and   achieve the learning goal of integrating knowledge, attitudes, and skills.

 

 

Main researcher: Professor Hsing-Chen YangGraduate Institute of Gender Studies, Kaohsiung Medical University

 

Author Email: yhc@kmu.edu.tw

Paper cited from:

Yang, H. C. (2019). Education first: Promoting LGBT+ friendly healthcare with a competency-based course and game-based teaching. International Journal of Environmental Research and Public Health, 17(1), 107; https://doi.org/10.3390/ijerph17010107

Research Paper available online on website: https://reurl.cc/Y6dxEO


將聚乙烯亞胺(Polyethylenimine, PEI)修飾到硫酸化軟骨素(Chondroitin sulfate, CS),形成一個PEI 接枝CS 之共聚物(簡稱CS-PEI)PEI是目前市售的一個黃金商品,具高轉染效能的非病毒式基因載體,但是PEI 所擁有的高正電荷密度也對細胞造成很高的毒性。本研究利用低分子量的PEI 接枝到天然的多醣體CS之側鏈上,一來解決臨床未來使用高分子量的PEI對細胞造成的毒性問題;二來以螞蟻雄兵之優勢,利用接掛多條低分子量PEI,使其仍然保留對基因的高轉染率。由於CD44常被發現於腫瘤細胞上,而CS可以辨識細胞膜表面的CD44受體,利用CS-PEI做為基因藥物載體,將增加CS-PEI攜帶之任何基因藥物對細胞表面過度表現CD44的腫瘤或腫瘤幹細胞的靶向性,經由CD44介導的胞飲作用,有效地進入細胞內,提高基因藥物在癌細胞的轉染效能。本研究即以這個低毒性、高轉染的CS-PEI來做為調控自噬作用的Beclin siRNA基因遞送載體;並以紫杉醇(Paclitaxel, PTX)抗藥性的腫瘤細胞株做為細胞模型(如肺癌NCI-H23-TXR),期待藉由抑制細胞的自噬作用,來恢復PTX對腫瘤組織的抑制生長效果。結果發現Beclin siRNA不但抑制Beclin蛋白表現,同時也抑制數個多重抗藥性蛋白的表現,進而促使PTX有效地抑制腫瘤組織的增生。本研究同時也建立一套利用斑馬魚植入腫瘤,快速篩選藥物抑制腫瘤生長的測試平台,未來此平台可延伸至其他腫瘤植入的動物模型。除此,本研究使用的基因載體材料CS-PEI已經獲准台灣專利(I434934)美國專利(US 8,445,025 B2; US 8,716,399 B2; US 9,050,362 B2),顯見此材料開發具有相當優越的市場開拓新契機。

01 劉旺達CH 下調多重抗藥性蛋白而提高紫杉醇對肺癌細胞的效益 

本校主要研究者之簡介:

本校醫藥暨應用化學系王麗芳教授領導的團隊,集結醫藥化學、生物醫學、奈米醫學、生醫工程、臨床醫學等跨領域專業人才,從化學合成、基因載體的設計、MDR細胞株的建立、自噬作用基因表現、班馬魚腫瘤植入之建立等等,是一個成功的跨系、院、校的成功例子。研究經費由科技部與高雄醫學大學共同支持。

研究聯繫Email: lfwang@kmu.edu.tw ; cchiu@kmu.edu.tw

期刊出處: Molecular Therapy: Nucleic Acids, 2019, 17(9), 477-490.

期刊線上參閱網址:

https://www.cell.com/action/showPdf?pii=S2162-2531(19)30180-5

Polyethyleneimine (PEI) is one of leading cationic polymer for gene delivery because of its high transfection efficiency. However, PEI induced high cytotoxicity due to the positively charged surface characteristics. Herein, we grafted PEI onto chondroitin sulfate (CS)  to yield CS-PEI which not only showed transgene efficiency, but reduced PEI cytotoxicity. CD44 is overexpressed in many solid tumor cells. It has been found that CS has the potential to be internalized into cells via CD44-mediated endocytosis. Thus, using CS-PEI as a gene drug delivery system, actively targeting to CD44-overexpressing cancer cells is an ideal approach to enhance transgene efficiency. Multidrug resistance (MDR) is the major obstacle in limitation of therapeutic efficacy of Paclitaxel (PTX). PTX-resistant non-small-cell lung cancer cell line (NCI-H23-TXR) was established and CS-PEI/Beclin-small interfering RNA (siRNA) was constructed to restore sensitivity of PTX against NCI-H23-TXR. Results revealed that knockdown of Beclin simultaneously inhibited MDR-related proteins, and renewed the sensitivity of PTX against NCI-H23-TXR. In vivo study showed that pre-transfection with CS-PEI/Beclin-siRNA followed by PTX treatment decreased the tumor size in NCI-H23-TXR zebrafish xenografts. (Taiwan Patent No. I434934; United States Patent US 8,445,025 B2; US 8,716,399 B2; US 9,050,362 B2)  

 01 劉旺達EN 下調多重抗藥性蛋白而提高紫杉醇對肺癌細胞的效益 

Main researcher Intro.

Dr. Li-Fang Wang, a professor of Department of Medicinal and Applied Chemistry at Kaohsiung Medical University.   

Author Email: lfwang@kmu.edu.tw ; cchiu@kmu.edu.tw 

Paper cited from: Molecular Therapy: Nucleic Acids, 2019, 17(9), 477-490. 

Paper online website:

https://www.cell.com/action/showPdf?pii=S2162-2531(19)30180-5 

量身訂做的教育介入提升兒童癌症存活者之健康行為自我效能


治療和照護的進步雖然提高癌症兒童的存活率,但兒癌存活者仍須面臨癌症和治療相關不利健康的結果。約60%的兒癌存活者至少罹患ㄧ種長期合併症,其中80%存活者的合併症需要接受治療。因此提高兒癌存活者徵狀管理之自我效能和健康促進行為,將有助於提高其自我效能,進而採取健康的生活方式。因此,規劃兒癌存活者的健康促進策略就顯得特別重要。

        本研究為隨機重複測量試驗,利用自我效能理論,首創兒童癌症存活者衛教課程,內容包含:建立自我意識(了解疾病和治療的潛在副作用)、預防健康(飲食和運動)和促進健康(自我照顧和重返學校)。全程共設計6次活動,於一周結束,每次進行約45-60分鐘,並於衛教介入後一個月,4個月電訪追蹤,以提升兒癌存活者健康行為自我效能。

       結果顯示實驗組在健康行為自我效能和健康促進生活得分隨著時間而顯著增加(all p < 0.05),且教育介入後4個月的健康行為自我效能得分顯著高於對照組(F= 5.32, p= 0.02, η2= 0.25),控制組在健康行為自我效能並未隨著時間顯著性改變。研究對象給與介入措施很高的評價(M=9.29)。本研究亦發現運動是癌症兒童存活者最大的障礙,設計簡單可行的運動,並能在住院期間執行,以及增加運動意願和持續的動機,都是未來努力的方向。未來研究可持續評值教育介入的長期效果,以及可能的聯動效益。

 

02 吳麗敏 CH量身訂做的教育介入提升兒童癌症存活者之健康行為自我效能

 透過隨機對照且持續追蹤4個月的實驗性研究設計,研究結果發現量身訂做的教育介入,可以提升兒癌存活者的健康行為自我效能進而促進健康生活型態

 

 

本校研究者之簡介:

1.        吳麗敏 高雄醫學大學護理學系教授兼系主任

2.        許心恬 高雄醫學大學護理學系副教授

3.         怡 高雄醫學大學護理學系副教授

4.        蘇秀蘭 高雄醫學大學附設中和紀念醫院專科護理師

 

研究聯繫Email:painting@kmu.edu.tw

期刊出處:

Li-Min Wu, Chin-Mi Chen, Hsin-Tien Hsu, Fan-Ray Kuo & Hsiu-Lan Su. (2019).
Tailored education enhances healthy behavior self-efficacy in childhood cancer survivors: A ramdomised controlled study with a 4-month follow up. 

 

研究全文下載:

https://pubmed.ncbi.nlm.nih.gov/31020742/

Tailored education enhances healthy behaviour selfefficacy in childhood cancer survivors: A randomised controlled study with a 4month followup


This study was to evaluate the acceptability and effectiveness of a tailored education on healthy behaviors selfefficacy (HBSE) and health promotion lifestyle (HPL) for childhood cancer survivors. A twogroup, randomized study with repeated measures was conducted in Taiwan. Participants were randomly assigned to receive six 45–60 min individual education and followup telephone counselling sessions (n = 34) or standard of care only (n = 35). Each participant was assessed with HBSE and HPL questionnaires and was evaluated at three time points (at baseline, and then 1 and 4 months after intervention). The attrition rate was 7.2%. HBSE and HPL scores increased across the three time points in the experimental group (all p < 0.05), except for the HBSE exercise subscale (p= 0.85). HBSE scores were significantly higher for the experimental group than for the control group after 4 months of intervention (F = 5.32, p = 0.02, η2 = 0.25). No significant improvements in HBSE were observed over time in the control group. The intervention was acceptable and effective in promoting HBSE in childhood cancer survivors. Further empirical work is needed to reveal the effects of the intervention over a longer period of time and to improve patient engagement in exercise.

 

02 吳麗敏 EN量身訂做的教育介入提升兒童癌症存活者之健康行為自我效能

A tailored education can improve childhood cancer survivors’ health behavior self-efficacy by conducting the randomized controlled study with a 4month followup

 

Main researcher Intro.

https://pubmed.ncbi.nlm.nih.gov/31020742/ 

 

Researcher

1. LiMin Wu RN, PhD, Professor, chair, School of Nursing, Kaohsiung Medical

University, and Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

2. ChinMi Chen RN, PhD, Associate Professor, Department of Nursing, Fu Jen Catholic

University, New Taipei City, Taiwan. 

3. HsinTien Hsu RN, PhD, Associate Professor, School of Nursing, Kaohsiung Medical

University, and Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. 

4. Yi Liu RN, PhD, Associate Professor, School of Nursing, Kaohsiung Medical

University, Kaohsiung, Taiwan.

5. HsiuLan Su RN, MSN, Nurse Practitioner, School of Nursing, Kaohsiung Medical

University, and Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. 

Author Email: painting@kmu.edu.tw

Paper cited from:

Li-Min Wu, Chin-Mi Chen, Hsin-Tien Hsu, Fan-Ray Kuo & Hsiu-Lan Su (2019). Tailored education enhances healthy behavior self-efficacy in childhood cancer survivors: A ramdomised controlled study with a 4-month follow up.

 

Research Paper available online on website

https://pubmed.ncbi.nlm.nih.gov/31020742/

三陰性乳癌新進展-奈米級白蛋白載體新藥

有「乳癌殺手」之稱之三陰性乳癌好發於40歲前,且其來自於名為BRCA-1基因所發生之變異疾病,也是讓女星安潔莉娜裘莉發現自己具有BRCA基因變異後,選擇切除乳房作為預防癌症發生之主因,近年來透過癌細胞基因解密讓乳癌分類更加明朗化,乳癌基因表現大致分為三類:雌激素受體(ER)、黃體素受體(PR)、人類上皮生長受體第二對(HER-2),如癌細胞三種基因表現皆為陰性則歸類為「三陰性乳癌」,目前是臨床上治癒率最低、復發率最高之乳癌類型,導致選用標靶藥物存在諸多限制,病患仍使用化學治療為主。

近日,高雄醫學大學方逸萍副教授及其研究生林欣哲之論文刊登於國際知名藥劑領域期刊,研究中指出「抗癌藥SN-38 白蛋白奈米載體」是針對三陰性乳癌新劑型藥物,SN-38為有強大抗癌活性之喜樹鹼衍生物,但因難溶於水且副作用大等特性限制了其於臨床上之應用;為此,方老師研究團隊藉由研發白蛋白奈米載體結合SN-38之技術克服其於臨床使用限制。白蛋白為人體內生性蛋白所構成,是血漿中最豐富蛋白質、能維持血漿滲透壓、運送血液營養物等,除了是人體中不可或缺之蛋白質外,也容易被代謝且不易致敏,利用白蛋白結構中之親水性及親脂性特質,可有效將SN-38包裹在奈米粒子之間。方老師研究團隊所合成之「抗癌藥SN-38 白蛋白奈米載體」經細胞實驗證實:可有效抑制三陰性乳癌細胞株生長,且白蛋白奈米粒子可增加SN-38進入癌細胞之有效劑量,且SN-38從奈米粒子釋出後更可標靶精準毒殺癌細胞。  

乳癌有逐漸年輕化之趨勢,多數年輕患者在發現乳癌當下,家庭與事業皆處於黃金時期,一旦確診三陰性乳癌除了生理上不適,心裡也會帶來諸多壓力,期待新劑型開發能順利進行,未來上市後作為治療三陰性乳癌之新選擇。 
11 SN 38 CH

本篇為高雄醫學大學2019年月傑出論文11月份得獎文章,代表作者為藥學系方逸萍副教授。  

本校主要研究者之簡介 

研究聯繫Email:

ypfang@kmu.edu.tw

期刊出處:

Pharmaceutics 2019, 11, 569

期刊線上參閱網址:

https://pubmed.ncbi.nlm.nih.gov/31683822/

The Progress in Triple Negative Breast Cancer Research Continues: the albumin nano drug carrier

Triple negative breast cancer (TNBC), related to BRCA1 mutation, is an aggressive breast cancer common in female younger than age 40. Potentially being in the TNBC population, the actress Angelina Jolie made the difficult decision to undergo a preventative mastectomy due to the alarming nature of TNBC. Lacking estrogen receptor (ER), progesterone receptor (PR) and HER2 receptor, TNBC has limited options on targeted medications, which results in low survival rate and high recurrence among the breast cancer subtypes. 

Recently, Professor Yi-Ping Fang with graduate student Hsin-Che Lin in Kaohsiung Medical University published a research on “anticancer agent SN-38 entrapped albumin nanoparticles to TNBC.” SN-38 is a camptothecin derivative with very potent anticancer effect. The clinical application of SN-38, however, is limited by its low solubility and serious adverse effects. For this reason, Professor Fang’s team proposed a solution to combine SN-38 with albumin carrier, considering albumin is not only one of the most abundant protein in human and maintains osmotic pressure, delivers substances in blood circulation, but also can be easily metabolized and further eliminated. By utilizing the natural amphiphilic property of albumin, Professor Fang’s team developed a procedure to formulate SN-38 in albumin nanoparticles which further showed promising targeting effect by accumulation these albumin nanoparticles in TNBC cell line to suppress TNBC cell line growth.

Upon the trend of younger breast cancer diagnosed such as TNBC in this case, majority of breast cancer patients are at their pinnacle of life and career, and this disease only brings serious distress physically and mentally. Through this research, the contribution to the solution to the unmet TNBC clinical need may be expected, with the ultimate goal in mind, to improve TNBC patients’ quality of life.
11 SN 38 EN

This article-“High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple- Negative Breast Cancer” , written by Rept. Author Associate Professor Yi-Ping Fang from School of Pharmacy, is award for Kaohsiung Medical University 2019 Monthly Excellent Paper Award in Nov.

Main researcher Intro.

Author Email: ypfang@kmu.edu.tw

Paper cited from: Pharmaceutics 2019, 11, 569

Paper online website: https://pubmed.ncbi.nlm.nih.gov/31683822/

第 31 頁,共 40 頁